Artal Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,000,000
Closed -$62.4M 138
2021
Q4
$62.4M Hold
1,000,000
1.69% 15
2021
Q3
$59.2M Hold
1,000,000
1.32% 21
2021
Q2
$66.8M Hold
1,000,000
1.36% 17
2021
Q1
$63.1M Hold
1,000,000
1.12% 23
2020
Q4
$62M Buy
+1,000,000
New +$61.5M 1.33% 20
2019
Q4
Sell
-3,500,000
Closed -$177M 101
2019
Q3
$177M Buy
3,500,000
+1,250,000
+56% +$58.7M 7.12% 3
2019
Q2
$102M Buy
2,250,000
+1,600,000
+246% +$74.5M 4.13% 4
2019
Q1
$31M Buy
650,000
+100,000
+18% +$4.98M 1.27% 22
2018
Q4
$28.6M Sell
550,000
-200,000
-27% -$10.7M 1.06% 21
2018
Q3
$46.6M Sell
750,000
-500,000
-40% -$29.7M 1.21% 16
2018
Q2
$69.2M Buy
1,250,000
+350,000
+39% +$18.9M 1.47% 7
2018
Q1
$56.9M Hold
900,000
0.71% 16
2017
Q4
$55.2M Buy
900,000
+250,000
+38% +$15.6M 0.83% 12
2017
Q3
$41.4M Sell
650,000
-350,000
-35% -$20.4M 0.71% 7
2017
Q2
$55.7M Hold
1,000,000
0.97% 9
2017
Q1
$54.4M Buy
1,000,000
+200,000
+25% +$11M 1.21% 7
2016
Q4
$46.8M Hold
800,000
1.04% 10
2016
Q3
$43.1M Buy
+800,000
New +$51.4M 0.85% 9
2016
Q1
Sell
-500,000
Closed -$34.4M 64
2015
Q4
$34.4M Hold
500,000
0.65% 15
2015
Q3
$29.6M Buy
+500,000
New +$31.7M 0.66% 20
2015
Q1
Sell
-400,000
Closed -$23.6M 77
2014
Q4
$23.6M Sell
400,000
-600,000
-60% -$33.8M 0.83% 28
2014
Q3
$51.2M Buy
1,000,000
+200,000
+25% +$9.99M 1.88% 7
2014
Q2
$38.8M Buy
800,000
+300,000
+60% +$14.8M 1.57% 9
2014
Q1
$26M Buy
+500,000
New +$26.6M 0.94% 22

Other funds holding BMY